IL6 and atherosclerosis: A study involving 37 individuals at heightened risk for atherosclerosis, who were undergoing standard CVD treatment, demonstrated that G. lucidum PsP significantly reduced levels of hs‐CRP, IL‐6, TNF‐α, and MDA (Widya et al. 2016).